Join to View Full Profile
875 Blake Wilbur DrPalo Alto, CA 94304
Phone+1 650-498-6000
Dr. Kang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2007 - 2010
Yonsei University College of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2018 - 2027
GA State Medical License 2025 - 2027
MD State Medical License 2013 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2015
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations Start of enrollment: 2018 Dec 14
- A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies Start of enrollment: 2019 Feb 11
- A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) Start of enrollment: 2020 Jan 22
- Join now to see all
Publications & Presentations
PubMed
- Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement.Sophie Leboulleux, Laura Boucai, Naifa Busaidy, Cosimo Durante, James A Fagin
The Lancet. Diabetes & Endocrinology. 2025-06-01 - A pilot study of PSMA-targeted F-18-DCFPyL PET imaging of patients with adenoid cystic carcinoma.Andrew F Voter, Alireza Amindarolzarbi, Colette J Shen, Jarey Wang, Hyunseok Kang
Scientific Reports. 2025-05-16 - 2 citationsNeutrophil-to-Lymphocyte Ratio and Pembrolizumab Outcomes in Oral Cavity Squamous Cell Carcinoma.Angeline A Truong, Rex H Lee, Xin Wu, Alain P Algazi, Hyunseok Kang
Otolaryngology--Head and Neck Surgery. 2025-02-01
Journal Articles
- Exceptional Responses to Pertuzumab, Trastuzumab, and Docetaxel in Human Epidermal Growth Factor Receptor‐2 High Expressing Salivary Duct CarcinomasLisa Rooper, Robert D Foss, Hyunseok Kang, Rishi Sawhney, Nicole C Schmitt, Head & Neck
- Pattern of Planned Systemic Therapy Usage in Newly Diagnosed, Nonmetastatic Squamous Cell Carcinoma of the Head and Neck in a Commercially Insured Population in the Un...Christine G Gourin, Ranee Mehra, Hyunseok Kang, Arlene A Forastiere, Ana P Kiess, Head & Neck
- Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1‐Deficient CarcinomaJosh Lauring, Lisa Rooper, Sarah Sagorsky, Hyunseok Kang, The Oncologist
Press Mentions
Effect of Coffee and Tea Consumption on Head and Neck Cancer RiskApril 17th, 2025
FDA Approves Pembrolizumab for Head and Neck CancerAugust 24th, 2016
Rivoceranib Elicits Promising Responses in Adenoid Cystic CarcinomaDecember 15th, 2022
Committees
- Member, Clinical Affairs Committee, American Thyroid Association 2023 - Present
- Member, Membership Committee, Society for Immunotherapy of Cancer 2019 - Present
- Chair, Oral, Head and Neck Site Committee, UCSF Helen Diller Comprehensive Comprehensive Cancer Center 2024 - 2025
- Member, Protocol Review Committee, UCSF Helen Diller Family Comprehensive Cancer Center 2022 - 2025
- Co-director of Oncology Grand Rounds, Educational Committee, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2015 - 2018
- Member, Safety Monitoring Committee, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2015 - 2018
Professional Memberships
- Fellow
- Member
- Member
- Member
- Member
- Society for Immunotherapy of CancerMember
- International Thyroid Oncology Group (ITOG)Member
Other Languages
- Korean, Japanese
External Links
- UCSFhttp://www.ucsf.edu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
